Following the earnings release, Chemed's stock price increased by 3.83%, reflecting investor confidence in the company's financial health and future prospects. The stock closed at $566.68, moving closer to its 52-week high of $654.62, indicating strong market sentiment. InvestingPro analysis shows the stock typically trades with low volatility, with a beta of just 0.48, making it an potentially attractive option for stability-focused investors. The company's strong Altman Z-Score of 16.67 further underscores its financial stability.